New Zealand markets open in 9 hours 27 minutes

ABBV Mar 2024 195.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.0500-0.2700 (-84.37%)
As of 09:44AM EST. Market open.
Full screen
Previous close0.3200
Open0.0500
Bid0.0100
Ask0.1100
Strike195.00
Expiry date2024-03-15
Day's range0.0500 - 0.0500
Contract rangeN/A
Volume1
Open interest356
  • Bloomberg

    Bond Markets Are Flooded With Deals to Fund M&A

    (Bloomberg) -- Demand has grown so fervent for corporate bonds that investors are once again willing to finance big mergers and acquisitions — something they hesitated to do for much of last year.Most Read from BloombergBuffett Says ‘Eye-Popping’ Results Unlikely With Record CashTrump Advances 2024 Bid Besting Haley in Her Home StateBezos, Nvidia Join OpenAI in Funding Humanoid Robot StartupFed-Favored Inflation Gauge Seen Rising Most in a YearLitquidity Salary Reports Help Bankers Measure Up An

  • Zacks

    Pharma Stock Roundup: Pfizer's Velsipity Receives EU Nod, ABBV Gets New CEO & More

    European Commission approves Pfizer's (PFE) Velsipity ulcerative colitis (UC) pill. AbbVie (ABBV) appoints Robert A. Michael as the new CEO.

  • Bloomberg

    AbbVie Sells $15 Billion of Bonds to Buy ImmunoGen, Cerevel

    (Bloomberg) -- Pharmaceutical giant AbbVie Inc. sold $15 billion of bonds in the US investment-grade market on Thursday to help fund its acquisitions of ImmunoGen Inc. and Cerevel Therapeutics Holdings Inc., adding to a recent rush of buyout financings. Most Read from BloombergNvidia Rises Most in About Nine Months as AI Drives SalesT-Bills Without Tax Bills? This Fund Says It Cracked the CodeStocks Rally as AI Craze Sweeps Across the World: Markets WrapAT&T Outage Triggered by Company Work on N